☰

Franklin R. Toapanta, Ph.D. - Publications

Affiliations: 
2006 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Immunology, Microbiology Biology
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Toapanta FR, Hu J, Meron-Sudai S, Mulard LA, Phalipon A, Cohen D, Sztein MB. Further characterization of -specific (memory) B cells induced in healthy volunteer recipients of SF2a-TT15, a 2a synthetic glycan-based vaccine candidate. Frontiers in Immunology. 14: 1291664. PMID 38022674 DOI: 10.3389/fimmu.2023.1291664  0.307
2023 Allen JC, Toapanta FR, Baliban SM, Sztein MB, Tennant SM. Reduced immunogenicity of a live serovar Typhimurium vaccine in aged mice. Frontiers in Immunology. 14: 1190339. PMID 37207226 DOI: 10.3389/fimmu.2023.1190339  0.366
2022 Hernandez AM, Mossman JA, Toapanta FR, Previte DM, Ross TM, Nau GJ. Altered transcriptional responses in the lungs of aged mice after influenza infection. Immunity & Ageing : I & A. 19: 27. PMID 35650631 DOI: 10.1186/s12979-022-00286-9  0.539
2021 Higginson EE, Panda A, Toapanta FR, Terzi MC, Jones JA, Sen S, Permala-Booth J, Pasetti MF, Sztein MB, DeTolla L, Levine MM, Tennant SM. Immunogenicity and efficacy of live-attenuated murium vaccine candidate CVD 1926 in a rhesus macaque model of gastroenteritis. Infection and Immunity. IAI0008721. PMID 34310885 DOI: 10.1128/IAI.00087-21  0.352
2020 Allen JC, Toapanta FR, Chen W, Tennant SM. Understanding immunosenescence and its impact on vaccination of older adults. Vaccine. PMID 33229108 DOI: 10.1016/j.vaccine.2020.11.002  0.395
2020 Edelman R, Deming ME, Toapanta FR, Heuser MD, Chrisley L, Barnes RS, Wasserman SS, Blackwelder WC, Handwerger BS, Pasetti M, Siddiqui KM, Sztein MB. The SENIEUR protocol and the efficacy of hepatitis B vaccination in healthy elderly persons by age, gender, and vaccine route. Immunity & Ageing : I & A. 17: 9. PMID 32355503 DOI: 10.1186/S12979-020-00179-9  0.452
2019 Mani S, Toapanta FR, McArthur MA, Qadri F, Svennerholm AM, Devriendt B, Phalipon A, Cohen D, Sztein MB. Role of antigen specific T and B cells in systemic and mucosal immune responses in ETEC and Shigella infections, and their potential to serve as correlates of protection in vaccine development. Vaccine. PMID 31230883 DOI: 10.1016/J.Vaccine.2019.03.040  0.48
2018 Hegerle N, Choi M, Sinclair J, Amin MN, Ollivault-Shiflett M, Curtis B, Laufer RS, Shridhar S, Brammer J, Toapanta FR, Holder IA, Pasetti MF, Lees A, Tennant SM, Cross AS, et al. Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. Plos One. 13: e0203143. PMID 30188914 DOI: 10.1371/Journal.Pone.0203143  0.428
2018 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB. Correction: A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. Plos One. 13: e0196367. PMID 29672646 DOI: 10.1371/Journal.Pone.0196367  0.384
2018 Toapanta FR, Bernal PJ, Kotloff KL, Levine MM, Sztein MB. T cell mediated immunity induced by the live-attenuated Shigella flexneri 2a vaccine candidate CVD 1208S in humans. Journal of Translational Medicine. 16: 61. PMID 29534721 DOI: 10.1186/S12967-018-1439-1  0.436
2018 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB. A clinically parameterized mathematical model of Shigella immunity to inform vaccine design. Plos One. 13: e0189571. PMID 29304144 DOI: 10.1371/Journal.Pone.0189571  0.502
2017 Keef E, Zhang LA, Swigon D, Urbano A, Ermentrout GB, Matuszewski M, Toapanta FR, Ross TM, Parker RS, Clermont G. Discrete dynamical modeling of influenza infection suggests age-dependent differences in immunity. Journal of Virology. PMID 28904202 DOI: 10.1128/Jvi.00395-17  0.62
2016 Toapanta FR, Bernal PJ, Fresnay S, Magder LS, Darton TC, Jones C, Waddington CS, Blohmke CJ, Angus B, Levine MM, Pollard AJ, Sztein MB. Oral Challenge with Wild-Type Salmonella Typhi Induces Distinct Changes in B Cell Subsets in Individuals Who Develop Typhoid Disease. Plos Neglected Tropical Diseases. 10: e0004766. PMID 27300136 DOI: 10.1371/Journal.Pntd.0004766  0.395
2015 Boianelli A, Nguyen VK, Ebensen T, Schulze K, Wilk E, Sharma N, Stegemann-Koniszewski S, Bruder D, Toapanta FR, Guzmán CA, Meyer-Hermann M, Hernandez-Vargas EA. Modeling Influenza Virus Infection: A Roadmap for Influenza Research. Viruses. 7: 5274-304. PMID 26473911 DOI: 10.3390/V7102875  0.416
2015 Toapanta FR, Bernal PJ, Fresnay S, Darton TC, Jones C, Waddington CS, Blohmke CJ, Dougan G, Angus B, Levine MM, Pollard AJ, Sztein MB. Oral Wild-Type Salmonella Typhi Challenge Induces Activation of Circulating Monocytes and Dendritic Cells in Individuals Who Develop Typhoid Disease. Plos Neglected Tropical Diseases. 9: e0003837. PMID 26065687 DOI: 10.1371/Journal.Pntd.0003837  0.375
2015 Price I, Mochan-Keef ED, Swigon D, Ermentrout GB, Lukens S, Toapanta FR, Ross TM, Clermont G. The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study. Journal of Theoretical Biology. 374: 83-93. PMID 25843213 DOI: 10.1016/J.Jtbi.2015.03.017  0.567
2014 Toapanta FR, Simon JK, Barry EM, Pasetti MF, Levine MM, Kotloff KL, Sztein MB. Gut-Homing Conventional Plasmablasts and CD27(-) Plasmablasts Elicited after a Short Time of Exposure to an Oral Live-Attenuated Shigella Vaccine Candidate in Humans. Frontiers in Immunology. 5: 374. PMID 25191323 DOI: 10.3389/Fimmu.2014.00374  0.514
2014 Booth JS, Toapanta FR, Salerno-Goncalves R, Patil S, Kader HA, Safta AM, Czinn SJ, Greenwald BD, Sztein MB. Characterization and functional properties of gastric tissue-resident memory T cells from children, adults, and the elderly. Frontiers in Immunology. 5: 294. PMID 24995010 DOI: 10.3389/Fimmu.2014.00294  0.349
2014 Hernandez-Vargas EA, Wilk E, Canini L, Toapanta FR, Binder SC, Uvarovskii A, Ross TM, Guzmán CA, Perelson AS, Meyer-Hermann M. Effects of aging on influenza virus infection dynamics. Journal of Virology. 88: 4123-31. PMID 24478442 DOI: 10.1128/Jvi.03644-13  0.616
2013 Seekatz AM, Panda A, Rasko DA, Toapanta FR, Eloe-Fadrosh EA, Khan AQ, Liu Z, Shipley ST, Detolla LJ, Sztein MB, Fraser CM. Differential response of the cynomolgus macaque gut microbiota to Shigella infection. Plos One. 8: e64212. PMID 23755118 DOI: 10.1371/Journal.Pone.0064212  0.452
2013 Davis CL, Wahid R, Toapanta FR, Simon JK, Sztein MB, Levy D. Applying mathematical tools to accelerate vaccine development: modeling Shigella immune dynamics. Plos One. 8: e59465. PMID 23589755 DOI: 10.1371/Journal.Pone.0059465  0.496
2012 Toapanta FR, Bernal PJ, Sztein MB. Diverse phosphorylation patterns of B cell receptor-associated signaling in naïve and memory human B cells revealed by phosphoflow, a powerful technique to study signaling at the single cell level. Frontiers in Cellular and Infection Microbiology. 2: 128. PMID 23087912 DOI: 10.3389/Fcimb.2012.00128  0.313
2012 Chen WH, Toapanta FR, Shirey KA, Zhang L, Giannelou A, Page C, Frieman MB, Vogel SN, Cross AS. Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. Immunology Letters. 141: 227-34. PMID 22037624 DOI: 10.1016/J.Imlet.2011.10.009  0.402
2011 Brown BN, Price IM, Toapanta FR, DeAlmeida DR, Wiley CA, Ross TM, Oury TD, Vodovotz Y. An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Mathematical Biosciences. 231: 186-96. PMID 21385589 DOI: 10.1016/J.Mbs.2011.03.005  0.466
2010 Toapanta FR, DeAlmeida DR, Dunn MD, Ross TM. C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunology Letters. 129: 32-8. PMID 20064559 DOI: 10.1016/J.Imlet.2009.12.022  0.534
2009 Toapanta FR, Ross TM. Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory Research. 10: 112. PMID 19922665 DOI: 10.1186/1465-9921-10-112  0.651
2008 Bright RA, Carter DM, Crevar CJ, Toapanta FR, Steckbeck JD, Cole KS, Kumar NM, Pushko P, Smith G, Tumpey TM, Ross TM. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. Plos One. 3: e1501. PMID 18231588 DOI: 10.1371/Journal.Pone.0001501  0.611
2007 Toapanta FR, Craigo JK, Montelaro RC, Ross TM. Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Current Hiv Research. 5: 199-209. PMID 17346134 DOI: 10.2174/157016207780077057  0.581
2007 Bright RA, Carter DM, Daniluk S, Toapanta FR, Ahmad A, Gavrilov V, Massare M, Pushko P, Mytle N, Rowe T, Smith G, Ross TM. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine. 25: 3871-8. PMID 17337102 DOI: 10.1016/J.Vaccine.2007.01.106  0.629
2006 Toapanta FR, Ross TM. Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunologic Research. 36: 197-210. PMID 17337780 DOI: 10.1385/Ir:36:1:197  0.586
2005 Bower J, Toapanta F, Young K, Ross T. Retrovirology. 2: S119. DOI: 10.1186/1742-4690-2-S1-S119  0.581
2005 Toapanta F, Ross T. Retrovirology. 2: P96. DOI: 10.1186/1742-4690-2-S1-P96  0.625
2004 Haas KM, Toapanta FR, Oliver JA, Poe JC, Weis JH, Karp DR, Bower JF, Ross TM, Tedder TF. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Journal of Immunology (Baltimore, Md. : 1950). 172: 5833-7. PMID 15128761 DOI: 10.4049/Jimmunol.172.10.5833  0.566
2004 Toapanta FR, Ross TM. Mouse strain-dependent differences in enhancement of immune responses by C3d. Vaccine. 22: 1773-81. PMID 15068861 DOI: 10.1016/J.Vaccine.2003.10.050  0.633
Show low-probability matches.